Leading pharmaceutical manufacturer Wockhardt Monday signed an in-licensing agreement with a British company specialising in dermatology to market a patented product for the treatment of a pigmentation disorder.

Monsters and Critics (http://news.monstersandcritics.com/business/article_1169805.php/Wockhardt_inks_deal_with_British_firm)